Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SIMILIA AS
AS
Active
Org 989248391
Teglverksveien 47, 3057 Solbergelva
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2006
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
-20% vs 2023
Equity ratio
41.0%
Financial strength
Net profit 2024
NOK 720K
+78% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -31K
-20%
Net profit
NOK 720K
+78%
Total assets
NOK 1,8M
+24%
Equity
NOK 735K
-11%
Employees
0
—
Company information
Legal name
SIMILIA AS
Org number
989248391
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
13. februar 2006
Share capital
NOK 226 827
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Torleiv idsøe holst
Company purpose
Investerings- og holdingvirksomhet og alt som står i forbindelse med dette, herunder investering og drift av eiendom
Contact
Address
Teglverksveien 47, 3057 Solbergelva
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Drammen
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
15
0
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−29
−37
−21
−26
−31
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−29
−37
−21
−26
−31
Net financials
148
141
200
429
751
Profit before tax
118
104
179
403
720
Tax
−0
−0
−0
−0
−0
Net profit
118
104
179
403
720
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 130
1 082
1 110
1 444
1 794
Equity
382
336
425
828
735
Long-term debt
550
550
550
550
550
Short-term debt
198
196
136
66
509
Total debt
748
746
686
616
1 059
Financial ratios
5-year trend
EBITDA margin
-3125400.0%
This company
15.8%
Market median
-19781113% vs market
2020
2024
Equity ratio
41.0%
This company
38.2%
Market median
+7% vs market
2020
2024
Return on equity
98.0%
This company
18.4%
Market median
+433% vs market
2020
2024
Net profit margin
71987900.0%
This company
8.1%
Market median
+888739406% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.44×
This company
0.62×
Market median
-132% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
EK
Eva Kristine Klokkerud
Board of Directors
2022
TI
Torleiv Idsøe Holst
Chairman
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Similia As
Company
2.09%
2.09%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
SIMILIA AS
(this company)
Balder Apotek As
NAMENA APOTEK AS
ARNIKA AS
Board network connections
Board members of SIMILIA AS also hold positions in
0
other companies.
Person
Role here
Other companies
Eva Kristine Klokkerud
Board of Directors
0 companies
Torleiv Idsøe Holst
Chairman
0 companies